World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
43640
World Ranking
4593
National Ranking
2494

Neuroscience

D-Index
114
Citations
43364
World Ranking
472
National Ranking
274

Ole Isacson publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Ole Isacson sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 371 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Ole Isacson D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Ole Isacson sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 114 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Ole Isacson is affiliated with Harvard University in the United States and has a research focus spanning multiple areas within medicine, biochemistry, genetics, molecular biology, and neuroscience. Their work primarily addresses neurological disorders, with a significant emphasis on Parkinson's disease and related mechanisms.

The main fields of study for Ole Isacson include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Neuroscience

Within these fields, the subfields of study covered in Isacson's publications include:

  • Neurology
  • Physiology
  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Cell Biology

Key research topics explored by Ole Isacson are:

  • Parkinson's Disease Mechanisms and Treatments
  • Lysosomal Storage Disorders Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Alzheimer's disease research and treatments
  • Cellular transport and secretion
  • Cholesterol and Lipid Metabolism
  • Nuclear Receptors and Signaling

Representative recent papers authored or co-authored by Ole Isacson include:

  • Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance, 2020, Proceedings of the National Academy of Sciences
  • Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients, 2020, Frontiers in Cellular Neuroscience
  • Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice, 2020, Molecular Therapy - Nucleic Acids
  • Glycosphingolipid metabolism and its role in ageing and Parkinson's disease, 2021, Glycoconjugate Journal
  • Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2, 2021, Molecular Brain

Ole Isacson frequently collaborates with a number of researchers, including:

  • Penelope J. Hallett
  • Ria Thomas
  • Kyle J. Connolly
  • Oeystein Roed Brekk
  • David A. Priestman

Their work has been published in venues such as:

  • Alzheimer s & Dementia
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Proceedings of the National Academy of Sciences
  • Frontiers in Cellular Neuroscience

In recognition of their contributions to science, Ole Isacson was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 2013.

Best Publications

  • Parkinson’s Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors

    Frank Soldner;Dirk Hockemeyer;Caroline Beard;Qing Gao

  • Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

    Marius Wernig;Jian Ping Zhao;Jan Pruszak;Eva Hedlund

  • Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

    Lars M. Björklund;Rosario Sánchez-Pernaute;Sangmi Chung;Therese Andersson;Therese Andersson

  • Specific MicroRNAs Modulate Embryonic Stem Cell–Derived Neurogenesis

    Anna M. Krichevsky;Kai‐C. Sonntag;Ole Isacson;Kenneth S. Kosik

  • Altered Proteasomal Function in Sporadic Parkinson's Disease

    Kevin St. P. McNaught;Roger Belizaire;Ole Isacson;Peter Jenner

  • Failure of the ubiquitin-proteasome system in Parkinson's disease.

    Kevin St P. McNaught;Kevin St P. McNaught;C. Warren Olanow;Barry Halliwell;Ole Isacson

  • Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

    Gunnar Hargus;Oliver Cooper;Michela Deleidi;Adam Levy

  • Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease

    Terrence Deacon;James Schumacher;Jonathan Dinsmore;Christine Thomas

  • Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

    Oliver Cooper;Hyemyung Seo;Shaida Andrabi;Cristina Guardia-Laguarta

  • Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years

    Ivar Mendez;Angel Viñuela;Arnar Astradsson;Karim Mukhida

  • Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection

    Chee Yeun Chung;Hyemyung Seo;Kai Christian Sonntag;Andrew Brooks

  • Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease

    Ivar Mendez;Rosario Sanchez-Pernaute;Oliver Cooper;Angel Viñuela

  • Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

    F. Cicchetti;A. L. Brownell;K. Williams;Y. I. Chen

  • Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy

    Chee Yeun Chung;James B. Koprich;Hasan Siddiqi;Ole Isacson

  • Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum

    O. Isacson;P. Brundin;P. A. T. Kelly;P. A. T. Kelly;F. H. Gage

  • α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.

    Joseph R. Mazzulli;Joseph R. Mazzulli;Friederike Zunke;Ole Isacson;Lorenz Studer

  • Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival.

    Brundin P;Isacson O;Björklund A

  • Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat

    D M Frim;T A Uhler;W R Galpern;M F Beal

  • Proteasome inhibition causes nigral degeneration with inclusion bodies in rats

    Kevin McNaught;Lars Björklund;Roger Belizaire;Ole Isacson

  • Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

    Penelope J. Hallett;Michela Deleidi;Arnar Astradsson;Gaynor A. Smith

  • Mechanisms of action of intracerebral neural implants: studies on nigral and striatal grafts to the lesioned striatum

    Anders Björklund;Olle Lindvall;Ole Isacson;Patrik Brundin

Frequent Co-Authors

Penelope J. Hallett
Penelope J. Hallett Harvard University
Anders Björklund
Anders Björklund Lund University
Anna-Liisa Brownell
Anna-Liisa Brownell Harvard University
Kwang-Soo Kim
Kwang-Soo Kim Harvard University
Xandra O. Breakefield
Xandra O. Breakefield Harvard University
Stephen B. Dunnett
Stephen B. Dunnett Cardiff University
Fred H. Gage
Fred H. Gage Salk Institute for Biological Studies
Bruce G. Jenkins
Bruce G. Jenkins Harvard University
Klas Wictorin
Klas Wictorin Lund University
Michael V. Sofroniew
Michael V. Sofroniew University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ole Isacson

Trending Scientists

Recently Published Articles